首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1789375

复合注射剂市场：按分子类型、治疗用途、产品类型、包装类型、给药途径、年龄层、分销管道、最终用户和地区划分

Complex Injectable Market, By Molecule Type, By Therapeutic Application, By Product Type, By Packaging Type, By Route of Administration, By Age Group, By Distribution Channel, By End User, By Geography

出版日期: 2025年07月29日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

复杂注射剂市场规模预计在 2025 年达到 261.1 亿美元，预计到 2032 年将达到 465 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 8.6%。

分析范围		分析详细信息
基准年	2024	市场规模（2025年）	261.1亿美元
效能数据	2020-2024	预测期	2025-2032
预测期间的复合年增长率（2025-2032年）	8.60%	预计金额（2032年）	465亿美元

全球复杂注射剂市场是製药业一个快速发展的领域，涵盖需要专门製造、处理和给药通讯协定的复杂药物传输系统。复杂注射涵盖各种产品，例如脂质体、微球、乳化、混悬液和其他先进剂型，由于其复杂的製造流程或独特的物理化学特性，这些产品难以复製。近年来，这些产品获得了显着的关注，因为与传统注射剂相比，它们具有更高的治疗效果、更高的患者依从性和更精准的药物传递能力。

该市场涵盖品牌复杂学名药和创新生技药品，服务于肿瘤学、免疫学、心臟病学和中枢神经系统疾病等重要治疗领域。慢性病发病率的上升、个人化医疗需求的不断增长以及全球医疗保健支出的不断增长，共同推动了该市场的显着增长。此外，几种重磅复杂注射药物的专利到期，为非专利药製造商创造了丰厚的机会，而药物输送系统的技术进步也持续推动着该领域的创新，使复杂注射剂成为现代医疗保健输送系统的重要组成部分。

市场动态

全球复方注射剂市场主要受多种强劲因素驱动，这些因素持续推动其成长轨迹。癌症、糖尿病、自体免疫疾病和心血管疾病等慢性疾病的增多，推动了对先进治疗方案的需求，而复方注射剂凭藉着卓越的生物利用度和标靶给药机制，能够提供这些方案。众多重磅复方注射的专利悬崖为非专利製造商带来了重大机会，他们可以透过生物相似药和学名药进入市场，从而扩大市场准入并降低医疗成本。药物传输系统的技术进步，例如奈米技术製剂、缓释性机制和精准医疗方法，正在推动创新并创造新的治疗可能性。

全球人口老化，加上新兴市场医疗支出的增加和医疗基础设施的发展，进一步推动了市场扩张。然而，市场面临重大製约，包括严格的监管要求，需要进行大量的临床试验和复杂的核准流程，以及显着增加的开发成本和上市时间。复杂的注射药物需要高度复杂的製造工艺，需要在专门的设施和设备上进行大量的资本投资，从而设置了进入障碍。此外，这些产品的技术复杂性对实现生物等效性和确保品质一致性提出了挑战，而有限的配方开发和监管专业知识限制了市场进入。儘管面临这些挑战，但也存在大量机会，包括医疗保健的数位化、向製药行业不断增长的新兴市场的扩张、创新者和非专利製造商之间的战略合作伙伴关係，以及针对新型药物输送技术和个性化医疗机会的持续研发。

本报告的主要特点

本报告对全球复杂注射剂市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
它还强调了每个领域的潜在商机，并描述了该市场的一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球复杂注射剂市场的主要企业已根据以下参数进行了分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
「全球复杂注射剂市场」报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球复杂注射剂市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 26.11 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 46.50 Bn

The global complex injectable market represents a rapidly evolving segment of the pharmaceutical industry, encompassing sophisticated drug delivery systems that require specialized manufacturing, handling, and administration protocols. Complex injectables include a diverse range of products such as liposomes, microspheres, emulsions, suspensions, and other advanced formulations that cannot be easily replicated due to their intricate manufacturing processes and unique physicochemical properties. These products have gained significant traction in recent years as they offer enhanced therapeutic efficacy, improved patient compliance, and targeted drug delivery capabilities compared to conventional injectable formulations.

The market encompasses both branded complex generics and innovative biologics, serving critical therapeutic areas including oncology, immunology, cardiology, and central nervous system disorders. The increasing prevalence of chronic diseases, growing demand for personalized medicine, and rising healthcare expenditure globally have contributed to the substantial growth of this market. Additionally, the patent expiration of several blockbuster complex injectable drugs has created lucrative opportunities for generic manufacturers, while technological advancements in drug delivery systems continue to drive innovation in this space, making complex injectables an essential component of modern healthcare delivery systems.

Market Dynamics

The global complex injectable market is primarily driven by several compelling factors that continue to propel its growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular diseases has created substantial demand for advanced therapeutic solutions that complex injectables can provide through their superior bioavailability and targeted delivery mechanisms. Patent cliffs of numerous blockbuster complex injectable drugs have opened significant opportunities for generic manufacturers to enter the market with biosimilar and generic versions, thereby expanding market accessibility and reducing healthcare costs. Technological advancements in drug delivery systems, including nanotechnology-based formulations, sustained-release mechanisms, and precision medicine approaches, are driving innovation and creating new therapeutic possibilities.

The growing aging population worldwide, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging markets, further supports market expansion. However, the market faces notable restraints including stringent regulatory requirements that demand extensive clinical trials and complex approval processes, significantly increasing development costs and time-to-market. The highly sophisticated manufacturing processes required for complex injectables necessitate substantial capital investments in specialized facilities and equipment, creating barriers for new entrants. Additionally, the technical complexity of these products poses challenges in achieving bioequivalence and ensuring consistent quality, while limited expertise in formulation development and regulatory affairs restricts market participation. Despite these challenges, opportunities abound through increasing healthcare digitalization, expansion in emerging markets with growing pharmaceutical sectors, strategic partnerships between innovator companies and generic manufacturers, and continuous research and development efforts focused on novel drug delivery technologies and personalized medicine approaches.

Key Features of the Study

This report provides in-depth analysis of the global complex injectable market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global complex injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc, Sanofi SA, GlaxoSmithKline plc, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc, AbbVie Inc, Bristol Myers Squibb, Takeda Pharmaceutical Co. Ltd, Biogen Inc, and Gilead Sciences Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global complex injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global complex injectable market

Market Segmentation

Molecule Type Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule
- Biologics-Based
Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Metabolic Disorders
- Hematological Disorders
- Neurological Disorders
- Ophthalmology
- Dermatology
- Cardiovascular Diseases
- Others (Rare Diseases)
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monoclonal Antibodies
- Peptides and Proteins
- Antibiotics
- Chemotherapy Agents
- Hormones
- Blood Factors
- Gene Therapy Products
- Cell Therapy Products
- Others (Oligonucleotides)
Packaging Type Insights (Revenue, USD Bn, 2020 - 2032)
- Vials
- Prefilled Syringes
- Ampoules
- Cartridges
- Others (IV Bags)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Intrathecal
- Intra-articular
- Other Parenteral Routes (Intradermal)
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Home Healthcare Settings
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc
- Novartis AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson
- Merck & Co., Inc
- Sanofi SA
- GlaxoSmithKline plc
- AstraZeneca PLC
- Eli Lilly and Company
- Amgen Inc
- AbbVie Inc
- Bristol Myers Squibb
- Takeda Pharmaceutical Co. Ltd
- Biogen Inc
- Gilead Sciences Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Complex Injectable Market, By Molecule Type
- Global Complex Injectable Market, By Therapeutic Application
- Global Complex Injectable Market, By Product Type
- Global Complex Injectable Market, By Packaging Type
- Global Complex Injectable Market, By Route of Administration
- Global Complex Injectable Market, By Age Group
- Global Complex Injectable Market, By Distribution Channel
- Global Complex Injectable Market, By End User
- Global Complex Injectable Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Complex Injectable Market, By Molecule Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Complex Injectable Market, By Therapeutic Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Complex Injectable Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Oligonucleotides)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Complex Injectable Market, By Packaging Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cartridges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (IV Bags)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Complex Injectable Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intra-articular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Parenteral Routes (Intradermal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Complex Injectable Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Complex Injectable Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Complex Injectable Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Complex Injectable Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

13. Competitive Landscape

Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

14. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

15. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

复合注射剂市场：按分子类型、治疗用途、产品类型、包装类型、给药途径、年龄层、分销管道、最终用户和地区划分